Skip to main content

Advertisement

ADVERTISEMENT

Volume 21 - Issue 8 - September, 2009

09/08/2009
Craig A. Thompson, MD, MMSc From the Director of Invasive Cardiology and Vascular Medicine and Associate Professor of Medicine, Yale University School of Medicine, New Haven, Connecticut. Disclosure: Dr Thompson is a consultant for Abbott Vascular, Asahi Intec, Bridgepoint Medical, and Medtronic. Address for correspondence: Craig A. Thompson, MD, MMSc, Director of Invasive Cardiology and Vascular, Yale University School of Medicine, PO Box 208017, 333 Cedar Street, New Haven, CT 06520-8017. E-mail: Craig.Thompson@Yale.edu
Craig A. Thompson, MD, MMSc From the...
ABSTRACT: Transradial intervention (TRI) approach has emerged as an alternative and competitive method compared with transfemoral intervention (TFI) approach for percutaneous coronary intervention (PCI) in simple to complex coronary disease....
ABSTRACT: Transradial intervention (TRI) approach has emerged as an alternative and competitive method compared with transfemoral intervention (TFI) approach for percutaneous coronary intervention (PCI) in simple to complex coronary disease....
ABSTRACT: Transradial...
09/08/2009
Journal of Invasive Cardiology
09/08/2009
1John P. Vavalle, MD; 1,2Sunil V. Rao, MD From 1Duke University Medical Center and 2The Duke Clinical Research Institute, both in Durham, North Carolina. Disclosure: Dr. Vavalle reports no conflicts of interest regarding the manuscript content herein. Dr. Rao receives research funding from Cordis Corporation, Momenta Pharmaceuticals, and Portola Pharmaceuticals, and receives honoraria for consulting or speaking for Sanofi-Aventis, Bristol Myers Squibb, and The Medicines Company. Address for correspondence: John P. Vavalle, MD, Duke University Medical Center, Division of Cardiovascular Medicine, Box 31356, Durham, NC 27710-0001. E-mail: jv18@notes.duke.edu
1John P. Vavalle, MD; 1,2Sunil V. Rao...
ABSTRACT: Bleeding complications after percutaneous coronary interventions (PCI) are a significant clinical problem associated with worse patient outcomes, including mortality. A number of studies have demonstrated that the majority of...
ABSTRACT: Bleeding complications after percutaneous coronary interventions (PCI) are a significant clinical problem associated with worse patient outcomes, including mortality. A number of studies have demonstrated that the majority of...
ABSTRACT: Bleeding complications...
09/08/2009
Journal of Invasive Cardiology
09/08/2009
Ronald P. Caputo, MD From St. Joseph’s Hospital, Syracuse, New York. Disclosure The author has disclosed no conflicts of interest regarding the content herein. Address for correspondence: Ronald P. Caputo, MD, FACC, FSCAI, SJH Cardiology Associates, 4820 W. Taft Rd., Liverpool, NY 13088. E-mail: caputo331@msn.com
Ronald P. Caputo, MD From St. Joseph...
ABSTRACT: The economic benefits of transradial compared to transfemoral access for percutaneous coronary procedures are derived from advantages primarily related to a lower incidence of access site complications and earlier ambulation. While...
ABSTRACT: The economic benefits of transradial compared to transfemoral access for percutaneous coronary procedures are derived from advantages primarily related to a lower incidence of access site complications and earlier ambulation. While...
ABSTRACT: The economic benefits...
09/08/2009
Journal of Invasive Cardiology
09/08/2009
Mauricio G. Cohen, MD; Carlos Alfonso, MD From the Cardiovascular Division, Miller School of Medicine, University of Miami, Miami, Florida. Disclosure: Dr. Cohen reports no conflicts of interest regarding the content herein. Dr. Alfonso reports no conflicts of interest regarding the content herein. Address for correspondence: Mauricio G. Cohen, MD, FACC, University of Miami Hospital, 1400 N.W. 12th Avenue, Room 1179, Miami, FL 33136. E-mail: mgcohen@med.miami.edu Acknowledgment: The authors acknowledge the excellent editorial assistance of Eric Scot Shaw in the preparation of this manuscript.
Mauricio G. Cohen, MD; Carlos Alfonso...
ABSTRACT: Over the past 20 years, since the first reports, trans-radial vascular access for coronary angiography and intervention has flourished in many countries while still accounting for less than 2% of all cases performed in the United...
ABSTRACT: Over the past 20 years, since the first reports, trans-radial vascular access for coronary angiography and intervention has flourished in many countries while still accounting for less than 2% of all cases performed in the United...
ABSTRACT: Over the past 20...
09/08/2009
Journal of Invasive Cardiology
09/08/2009
Jennifer A. Tremmel, MD, MS From Stanford University Medical Center, Stanford, California. Disclosure: Dr. Tremmel is a consultant for Terumo Medical Corporation. Address for correspondence: Jennifer A. Tremmel, MD, MS, FACC, Interventional Cardiology, Stanford University Medical Center, 300 Pasteur Drive, Room H2103, Stanford, CA 94305-5218. E-mail: jtremmel@cvmed.stanford.edu
Jennifer A. Tremmel, MD, MS From Sta...
ABSTRACT: There is an increasing interest in performing transradial (TR) procedures in the United States, but with so few experienced operators, developing a TR program often means figuring out a lot on one’s own. Certain necessary...
ABSTRACT: There is an increasing interest in performing transradial (TR) procedures in the United States, but with so few experienced operators, developing a TR program often means figuring out a lot on one’s own. Certain necessary...
ABSTRACT: There is an increasing...
09/08/2009
Journal of Invasive Cardiology
09/08/2009
Sunil V. Rao, MD From The Duke Clinical Research Institute, in Durham, North Carolina. Disclosure: Dr. Rao receives research funding from Cordis Corporation, Momenta Pharmaceuticals, and Portola Pharmaceuticals, and receives honoraria for consulting or speaking for Sanofi-Aventis, Bristol Myers Squibb, and The Medicines Company. Address for correspondence: Sunil V. Rao, MD, 508 Fulton Street (111A), Durham, NC 27705. E-mail: sunil.rao@duke.edu
Sunil V. Rao, MD From The Duke Clini...
Percutaneous coronary intervention (PCI) is one of the most commonly performed cardiac procedures. Since its introduction over two decades ago, there has been a steady evolution in both devices and pharmacotherapy. Data from large registries...
Percutaneous coronary intervention (PCI) is one of the most commonly performed cardiac procedures. Since its introduction over two decades ago, there has been a steady evolution in both devices and pharmacotherapy. Data from large registries...
Percutaneous coronary...
09/08/2009
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement